New York (AFP) – Pfizer reported a drop in second-quarter profits Tuesday, but lifted its full-year forecast on expectations that medical activities curtailed by coronavirus will return in the second half of 2020.The drugmaker, which is working on a vaccine for COVID-19, said it temporarily suspended clinical trials during the second quarter and halted marketing meetings with medical professionals, with the latter impacting new prescriptions in the United States and other markets. The company also suffered a hit of around $500 million from reduced visits to doctors by patients in the US due to…
source https://this.kiji.is/en/660828938340664417?c=648607265489716321